The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods

References

• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease2014 Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed September 19, 2015
   Google Scholar
• LiuYShiHSunXBenefits of adding fluticasone propionate/salmeterol to tiotropium in COPD: a meta-analysisEur J Intern Med201425549149524816076
   PubMed Web of Science ®Google Scholar
• RodrigoGJPlazaVCastro-RodriguezJAComparison of three combined pharmacological approaches with tiotropium monotherapy in stable moderate to severe COPD: a systematic reviewPulm Pharmacol Ther2012251404722085775
   PubMed Web of Science ®Google Scholar
• AaronSDVandemheenKLFergussonDTiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trialAnn Intern Med2007146854555517310045
   PubMed Web of Science ®Google Scholar
• CazzolaMAndoFSantusPA pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPDPulm Pharmacol Ther200720555656116914336
   PubMed Web of Science ®Google Scholar
• HananiaNACraterGDMorrisANEmmettAHO’DellDMNiewoehnerDEBenefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPDRespir Med201210619110122040533
   PubMed Web of Science ®Google Scholar
• HoshinoMOhtawaJEffects of tiotropium and salmeterol/fluticasone propionate on airway wall thickness in chronic obstructive pulmonary diseaseRespiration201386428028723880883
   PubMed Web of Science ®Google Scholar
• JungKSParkHYParkSYComparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled studyRespir Med2012106338238921975275
   PubMed Web of Science ®Google Scholar
• MaltaisFMahlerDAPepinVEffect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPDEur Respir J201342253954123904549
   PubMed Web of Science ®Google Scholar
• WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180874175019644045
   PubMed Web of Science ®Google Scholar
• SuttonAJCooperNJLambertPCJonesDRAbramsKRSweetingMJMeta-analysis of rare and adverse event dataExp Rev Pharmacoecon Outcomes Res200224367379
   PubMedGoogle Scholar
• National Evidence-based Healthcare Collaborating AgencyBayesian Meta-Analysis MethodSeoul, KoreaNECA2013
   Google Scholar
• SuttonAJAbramsKRJonesDRSheldonTASongFMethods for Meta-Analysis in Medical ResearchHoboken, NJWiley2000
   Google Scholar
• GuyattGHThorlundKOxmanADGRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomesJ Clin Epidemiol201366217318323116689
   PubMed Web of Science ®Google Scholar
• LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationAnn Intern Med20091514W65W9419622512
   PubMed Web of Science ®Google Scholar
• SpiegelhalterDJMylesJPJonesDRAbramsKRBayesian methods in health technology assessment: a reviewHealth Technol Assess2000438113011134920
   PubMedGoogle Scholar
• HigginsJPDeeksJJAltmanDGSpecial topics in statisticsHigginsJPGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0The Cochrane collaboration2011
   Google Scholar
• HigginsJPAltmanDGGotzschePCThe Cochrane Collaboration’s tool for assessing risk of bias in randomised trialsBMJ2011343d592822008217
   PubMed Web of Science ®Google Scholar
• WarnDEThompsonSGSpiegelhalterDJBayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scalesStat Med200221111601162312111922
   PubMed Web of Science ®Google Scholar
• PeterJVJohnPGrahamPLMoranJLGeorgeIABerstenACorticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysisBMJ200833676511006100918434379
   PubMed Web of Science ®Google Scholar
• GelmanARubinDInference from iterative simulation using multiple sequencesStat Sci19927457511
   Google Scholar
• BrooksSGelmanAGeneral methods for monitoring convergence of iterative simulationsJ Comput Graph Stat19977434455
   Web of Science ®Google Scholar
• SterneJAGavaghanDEggerMPublication and related bias in meta-analysis: power of statistical tests and prevalence in the literatureJ Clin Epidemiol200053111119112911106885
   PubMed Web of Science ®Google Scholar
• MartinezFJDonohueJFRennardSIThe future of chronic obstructive pulmonary disease treatment – difficulties of and barriers to drug developmentLancet201137897951027103721907866
   PubMed Web of Science ®Google Scholar
• JonesPWSt George’s Respiratory Questionnaire: MCIDCOPD200521757917136966
   PubMedGoogle Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• NiewoehnerDERiceKCoteCPrevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trialAnn Intern Med2005143531732616144890
   PubMed Web of Science ®Google Scholar
• DusserDBravoMLIaconoPThe effect of tiotropium on exacerbations and airflow in patients with COPDEur Respir J200627354755516507855
   PubMed Web of Science ®Google Scholar
• DecramerMCelliBKestenSEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet200937496961171117819716598
   PubMed Web of Science ®Google Scholar
• CelliBDecramerMKestenSMortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20091801094895519729663
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• CalverleyPPauwelsRVestboJCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet2003361935644945612583942
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J2003211748112570112
   PubMed Web of Science ®Google Scholar
• CalverleyPMBoonsawatWCsekeZZhongNPetersonSOlssonHMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J200322691291914680078
   PubMed Web of Science ®Google Scholar
• CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
   PubMed Web of Science ®Google Scholar
• VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
   PubMed Web of Science ®Google Scholar
• ChongJKarnerCPoolePTiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev20129CD00915722972134
   PubMed Web of Science ®Google Scholar
• DecramerMLChapmanKRDahlROnce-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group studyLancet Respir Med20131752453324461613
   PubMed Web of Science ®Google Scholar
• DecramerMDahlRKornmannOKornSLawrenceDMcBryanDEffects of long-acting bronchodilators in COPD patients according to COPD severity and ICS useRespir Med2013107222323223219347
   PubMed Web of Science ®Google Scholar
• VogelmeierCKardosPHarariSGansSJStengleinSThirlwellJFormoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month studyRespir Med2008102111511152018804362
   PubMed Web of Science ®Google Scholar
• KarnerCCatesCJLong-acting β(2)-agonist in addition to tiotropium versus either tiotropium or long-acting β(2)-agonist alone for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20124CD00898922513969
   PubMed Web of Science ®Google Scholar
• LeeCHJangEJHyunMKLeeNRKimKYimJJRisk of hospital admission or emergency room visit for pneumonia in patients using respiratory inhalers: a case-crossover studyRespirology20131871116112723711281
   PubMed Web of Science ®Google Scholar
• KewKMSeniukovichAInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseCochrane Database of Syst Rev20143CD01011524615270
   PubMed Web of Science ®Google Scholar
• CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
   PubMed Web of Science ®Google Scholar
• TantucciCModinaDLung function decline in COPDInt J Chron Obstruct Pulm Dis201279599
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar